Remove 2000 Remove Clinical Trials Remove Law Remove Treatment
article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. Minnesota Rep. Missouri Rep.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A New Treatment: CBD Oil For Autism?

Puff Puff Post

With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. The Current Treatments for Autism. CBD also helps to treat seizures, a common overlap for those with autism. What Exactly is Autism ?

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

article thumbnail

U.S. Funding Focuses on Marijuana’s Harms, Not Benefits

CannaMD

research funders, the National Institute on Drug Abuse (NIDA) , spent over $1 billion between 2000 and 2008, with a heavily slanted focus on cannabis abuse and misuse, as well as the negative effects of cannabis. While some funds are being used to study cannabis medical treatments, the majority of funding is still used to research harms.

DEA 105
article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

Current federal law expressly allows for the distribution of hemp-derived CBD products that contain 0.3% Other CBD products, however, are still subject to various state law regulations as well as the U.S. The public hearing attracted over 100 speakers and 2000 participants.

CBD 80
article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45